Tiamson, Cris Reyden B.
HRN: 22-48-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2024
CEFUROXIME 750MG (VIAL)
08/27/2024
09/02/2024
IV
600mg
Q8
Acute Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes